Beta-Thalassemia Completed Phase 4 Trials for Deferasirox (DB01609)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00564941Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron OverloadTreatment